Universal hepatitis B vaccination

The Lancet Infectious Diseases

Volumn 8, Issue 2, 2008, Pages 88-89

  Piazza, Marcello ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA VACCINE; HEPATITIS B VACCINE; POLIOMYELITIS VACCINE; TETANUS TOXOID;

ABSENCE OF SIDE EFFECTS; DIPHTHERIA; ENDEMIC DISEASE; HEPATITIS B; HIGH RISK POPULATION; HUMAN; INCIDENCE; LETTER; MUCOSA; POLIOMYELITIS; PREVALENCE; PRIORITY JOURNAL; TETANUS; VACCINATION;

CHILD; EUROPE; HEALTH POLICY; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; MASS IMMUNIZATION;

EID: 38349182523     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(08)70005-7     Document Type: Letter

References (16)

1. Zuckerman J., van Hattum J., Cafferkey M., et al. Should hepatitis B vaccination be introduced into childhood immunisation programmes in northern Europe?. Lancet Infect Dis 7 (2007) 410-419
2. US Department of Health Education and Welfare. Hepatitis surveillance III. Hepatitis B transmission modes: evidence against enteric transmission, report 41 (1977), Centers for Disease Control and Prevention, Atlanta, GA 20-22
3. Piazza M., Guadagnino V., Picciotto L., et al. Contamination by hepatitis B surface antigen in dental surgeries. BMJ 295 (1987) 473-476
4. Piazza M., Cacciatore L., Molinari V., and Picciotto L. Hepatitis B not transmissible via faecal-oral route. Lancet 2 (1975) 706
5. Piazza M., Picciotto L., Villari R., et al. Hepatitis B immunisation with a reduced number of doses in newborn babies and children. Lancet 1 (1985) 949-951
6. Piazza M., Picciotto L., Villari R., et al. Two-dose hepatitis B immunisation regimen for infants. Lancet 2 (1985) 1120-1121
7. Piazza M., Da Villa G., Picciotto L., et al. Mass vaccination against hepatitis B in infants in ltaly. Lancet 2 (1988) 1132
8. Da Villa G., Piazza M., lorio R., et al. A pilot study of vaccination against hepatitis B virus suitable for mass vaccination campaigns in hyperendemic areas. J Med Virol 36 (1992) 274-278
9. Anon. Mandatory vaccination against hepatitis B. Gazzetta Ufficiale della Repubblica Italiana 251 (1991) 3-4
10. Bonanni P., Pesavento C., Bechini A., et al. lmpact of universal vaccination programmes on the epidemiology of hepatitis B: 10 years of experience in ltaly. Vaccine 21 (2003) 685-691
11. Da Villa G., Romanò L., Sepe A., et al. Impact of hepatitis B vaccination in a highly endemic area of south Italy and long-term duration of anti-HBs antibody in two cohorts of vaccinated individuals. Vaccine 25 (2007) 3133-3136
12. Mele A., Mariano A., Tosti M., et al. Acute hepatitis Delta virus infection in Italy: incidence and risk factors after the introduction of the universal anti-hepatitis B vaccination campaign. Clin Infect Dis 44 (2007) 17-24
13. Squarcione S., Pompa M., and Vellucci L. Morbidity from hepatitis B after introduction of nationwide immunisation in ltaly. Lancet 350 (1997) 114
14. Alter M. Protecting future generations through immunization against hepatitis B. Ann Intern Med 135 (2001) 835-836
15. Poland G., and Jacobson R. Clinical practice: prevention of hepatitis B with the hepatitis B vaccine. N Engl J Med 351 (2004) 2832-2838
16. CDC. Global progress toward universal childhood hepatitis B vaccination, 2003. MMWR Morb Mortal Wkly Rep 52 (2003) 868-870